Utah Medical Products, Inc. (UTMD)

NASDAQ: UTMD · Real-Time Price · USD

72.12

+0.12 (0.17%)

Aug 19, 2026, 4:00 PM EDT - Market closed

Utah Medical Products Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	87.53	85.76	82.98	92.87	75.05	60.97
Cash & Short-Term Investments	87.53	85.76	82.98	92.87	75.05	60.97
Cash Growth	6.51%	3.35%	-10.65%	23.74%	23.09%	18.19%
Accounts Receivable	3.57	3.52	4.1	3.34	5.54	5.13
Other Receivables	-	0	-0	0.05	-	-
Receivables	3.57	3.52	4.09	3.39	5.54	5.13
Inventory	9	7.94	8.81	9.58	8.81	6.6
Prepaid Expenses	-	0.53	0.45	0.43	0.52	0.46
Total Current Assets	100.64	97.74	96.33	106.27	89.92	73.16
Property, Plant & Equipment	9.63	9.91	9.76	10.55	10.22	10.62
Goodwill	13.96	14.05	13.58	13.69	13.35	14.1
Other Intangible Assets	0.35	0.84	2.87	4.95	10.38	17.76
Total Assets	124.57	122.54	122.54	135.46	123.87	115.64

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.88	0.91	0.7	0.77	1.22	0.76
Accrued Expenses	1.19	2.47	3.1	3.36	4.2	2.85
Current Portion of Leases	-	0.06	-	-	-	-
Current Income Taxes Payable	-	-0.91	-0.15	0.33	0.34	0.04
Other Current Liabilities	-	0.07	0.11	0.26	0.2	0.1
Total Current Liabilities	2.07	2.6	3.76	4.71	5.96	3.75
Long-Term Leases	0.2	0.23	0.28	0.3	0.34	0.4
Long-Term Deferred Tax Liabilities	0.27	0.45	1.07	1.44	2.06	2.68
Other Long-Term Liabilities	-	-	-	0.7	1.26	1.68
Total Liabilities	2.54	3.27	5.11	7.15	9.62	8.5

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.03	0.03	0.03	0.04	0.04	0.04
Additional Paid-In Capital	-	-	-	0.59	0.25	0.84
Retained Earnings	131.95	128.65	129.3	138.34	126.01	115.31
Comprehensive Income & Other	-9.95	-9.42	-11.91	-10.66	-12.04	-9.05
Shareholders' Equity	122.03	119.27	117.43	128.31	114.25	107.14
Total Liabilities & Equity	124.57	122.54	122.54	135.46	123.87	115.64

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.2	0.29	0.28	0.3	0.34	0.4
Net Cash (Debt)	87.33	85.47	82.69	92.57	74.71	60.58
Net Cash Growth	6.60%	3.36%	-10.67%	23.91%	23.33%	18.19%
Net Cash Per Share	27.35	26.38	23.61	25.45	20.51	16.55
Filing Date Shares Outstanding	3.18	3.19	3.28	3.59	3.63	3.65
Total Common Shares Outstanding	3.18	3.19	3.34	3.63	3.63	3.66
Working Capital	98.57	95.14	92.57	101.56	83.96	69.41
Book Value Per Share	38.34	37.43	35.21	35.35	31.49	29.31
Tangible Book Value	107.73	104.38	100.98	109.68	90.52	75.28
Tangible Book Value Per Share	33.85	32.76	30.28	30.22	24.95	20.60
Land	-	1.7	1.6	1.64	1.59	1.69
Buildings	-	14.39	13.54	13.91	13.6	14.17
Machinery	-	19.06	18.53	17.32	17.07	16.66
Construction In Progress	-	0.11	0.02	1.41	0.91	0.9
Order Backlog	-	0.73	1.89	3.65	5.61	4.96

SEC Filings: 10-K · 10-Q